Home Blog Page 3103

UY Scuti Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Rights

By
Advertorial Desk
-

NEW YORK, May 21, 2025 /PRNewswire/ — UY Scuti Acquisition Corp. (Nasdaq: UYSCU) (the “Company”) announced today that, commencing Tuesday, May 27, 2025, holders of the units sold in the Company’s initial public offering of 5,750,000 units (“Units”) may commence separate trading of the underlying component securities. Each Unit consists of one ordinary share, par value $0.0001 per ordinary share (“Share”), and one right to receive one-fifth (1/5th) of one Share upon the consummation of the Company’s initial business combination (“Right”). Those units not separated will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol “UYSCU.”

The Shares and the Rights that are separated will trade on Nasdaq under the symbols “UYSC” and “UYSCR” respectively. Holders of units will need to have their securities brokers contact Continental Stock Transfer & Trust Company at 1 State Street, 30th Floor, New York, New York 10004, the Company’s transfer agent, in order to separate the Units into Shares and Rights.

The Units were initially offered by the Company in an underwritten offering through Maxim Group LLC, which acted as the sole book runner for the offering and as the representative of the underwriters in the offering. A registration statement on form S-1 relating to these securities (Sec File Number 333-284815) was declared effective by the Securities and Exchange Commission on March 31, 2025. Copies of the registration statement can be accessed through the SEC’s website at www.sec.gov.

UY Scuti Acquisition Corp.

UY Scuti Acquisition Corp. is a blank check company formed under the laws of the Cayman Islands for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Forward Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements, including those with respect to the Company’s search for an initial business combination, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements, including those set forth in the Risk Factors section of the Company’s registration statement and final prospectus for the Company’s initial public offering filed with the SEC. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based, except as required by law.

OKX and McLaren F1 Team Reveal Riviera Livery Honoring F1 Heritage

By
Advertorial Desk
-

MONACO, May 21, 2025 /PRNewswire/ — OKX, a leading global blockchain technology company and Official Primary Partner of the McLaren Formula 1 Team, along with McLaren Racing, today revealed a striking Riviera-inspired livery that will feature on McLaren’s MCL39 race cars at the upcoming 2025 Monaco and Spanish grands prix.

Monaco Heritage Livery 2025
Monaco Heritage Livery 2025

More than a visual statement, this livery represents a shared vision of transformation. It blends the spirit of the McLaren F1 Team’s 1960’s racing triumphs with the next generation of speed, simplicity, and digital creativity, fusing old-school grit with new-school style. It is also a mark of respect for the anniversary of the tragic passing of Bruce McLaren on June 2, 1970.

Just as the M7A broke new ground in 1968, delivering McLaren its first F1 win and introducing the now-legendary papaya, this new design marks a new milestone: OKX becoming the first cryptocurrency exchange to receive a MiCA license, opening the door to a New Alternative in European finance.

Watch the video here

This campaign is the fourth custom livery born from the OKX-McLaren partnership, highlighting a shared commitment to creativity, performance, and pushing boundaries. Celebrating the legacy of old money through the lens of new money.

“Over the years, Formula 1 has seen huge amounts of change, from technological developments to the recent growth in fandom, the sport’s culture has evolved and there’s a fantastic attitude of freedom to push the boundaries of what’s possible,” said Haider Rafique, Chief Marketing Officer, OKX. “This aligns perfectly with our mission to challenge conventional ways of thinking about money and finance and Riviera livery symbolizes this transformation and the elegance and innovation both OKX and McLaren are known for.”

Fans can look forward to seeing the Riviera-inspired livery on both McLaren MCL39s, driven by Lando Norris and Oscar Piastri, who will also wear exclusive OKX-branded A New Alternative race suits during the Monaco Grand Prix weekend.

From the sun-drenched streets of Monaco to the global stage of financial innovation, the Riviera livery connects McLaren’s legacy with OKX’s vision: a world where tradition meets transformation, old money gives way to new freedom, and boldness knows no boundaries.

About OKX

Trusted by more than 60 million customers around the globe, OKX is a technology company building a decentralized future that makes the world more tradable, transparent and connected. We’re known for being one of the fastest and most reliable crypto apps in the world, and have processed trillions of dollars in transactions.

We have key regional offices, including headquarters in San José, California, for the Americas and in Dubai for the Middle East. We also have offices in New York, Hong Kong, Singapore, the Republic of Türkiye, Australia and Europe.

Over the past several years, we’ve built one of the world’s most comprehensive regulatory compliant, licensed crypto companies. We hold licenses in the United States, the UAE, EEA, Singapore and Australia, as well as in other markets.

We’re steadfastly committed to transparency and security and publish Proof of Reserves reports on a monthly basis. To learn more about OKX, download our app or visit: okx.com.

Disclaimer

About McLaren Racing

McLaren Racing was founded by racing driver Bruce McLaren in 1963. The team entered its first Formula 1 race in 1966. McLaren has since won 21 Formula 1 world championships, 193 Formula 1 Grands Prix, the Indianapolis 500 three times, and the Le Mans 24 Hours at its first attempt. 

McLaren Racing competes across five racing series. The team competes in the FIA Formula 1 World Championship with McLaren F1 drivers Lando Norris and Oscar Piastri, the NTT INDYCAR SERIES with Arrow McLaren drivers Pato O’Ward, Nolan Siegel and Christian Lundgaard, the ABB FIA Formula E World Championship as the NEOM McLaren Formula E Team with drivers Sam Bird and Taylor Barnard, and F1 Academy with Driver Development programme member Ella Lloyd. The team also competes in the F1 Sim Racing Championship as McLaren Shadow with Lucas Blakeley, Wilson Hughes and Alfie Butcher.

McLaren is a champion for sustainability in the sport and a signatory to the UN Sports for Climate Action Commitment. It is committed to achieving net zero by 2040 and fostering a diverse and inclusive culture in the motorsport industry.

McLaren Racing – Official Website

Google Announces Partnership with Gentle Monster as a First Partner for AI Smart Eyewear with Android XR

By
Advertorial Desk
-

SINGAPORE, May 21, 2025 /PRNewswire/ — Google announced at I/O 2025 its partnership with Gentle Monster as a first partner for an AI smart eyewear collaboration with Android XR.

Google partnership with GENTLE MONSTER
Google partnership with GENTLE MONSTER

Gentle Monster is a global eyewear brand from South Korea, leading the trends in global eyewear through its innovative brand narrative with experimental yet sophisticated aesthetics.

Shahram Izadi, General Manager and Vice President, Google XR, emphasized that creativity and sophistication are essential design features for technology to integrate into everyday life. Gentle Monster as a first partner in the development of AI smart eyewear with Android XR was also highlighted as a pivotal step in the evolution of AI smart eyewear into essential, lifestyle fashion items.

Envisioning easy-to-wear products with both comfort and aesthetics as top priorities, the new partnership with Gentle Monster is set to seamlessly integrate extended reality into everyday life.

The announcement at Google I/O 2025 has sparked considerable anticipation for the eyewear that will showcase cutting-edge smart technology alongside the refined aesthetics of Gentle Monster.

Fibocom Releases 5G AI Mobile Hotspot Solution, Unlocking Intelligent Future for Mobile Broadband Devices

By
Advertorial Desk
-

TAIPEI , May 21, 2025 /PRNewswire/ — As 5G and AI technologies continue to converge, demand is growing for stable, high-speed, and intelligent mobile networks across various scenarios—from business travel and outdoor operations to global connectivity. Fibocom’s latest 5G AI Mobile Hotspot solution redefines the mobile broadband experience with cutting-edge technology and forward-thinking design.

Powered by Qualcomm’s advanced 4nm QCM4490 platform, the solution combines smartphone-grade ultra-low power consumption with precision circuit design. This results in a powerful yet energy-efficient platform that balances high performance with cost optimization.

In terms of connectivity, the solution supports 3GPP Release 16 and NR 2CC 120MHz. It delivers a downlink speed of up to 2.3 Gbps in SA mode and 2.5 Gbps in NSA mode. Customers can flexibly configure the solution with either AX3600-based Wi-Fi 6E or BE5800-based Wi-Fi 7 options. It supports dual-band simultaneous (DBS) modes of 2.4GHz+5GHz or 2.4GHz+6GHz, as well as high-band simultaneous (HBS) mode of 5GHz+6GHz.

Tailored for Mobile Hotspot applications, the solution runs an optimized Android 13 OS, significantly boosting system performance while reducing power consumption. With USB 3.1 support and a theoretical data transfer rate of up to 5 Gbps, it’s well-suited not only for 5G Mobile Hotspot devices but also for other mobile broadband terminals such as USB dongles.

Crucially, the solution leverages the QCM4490’s heterogeneous computing architecture, featuring a robust 8-core CPU (2x Cortex-A78 @ 2.4GHz + 6x Cortex-A55 @ 2.0GHz) and integrated Adreno 613 GPU (@ 1010MHz). Compared to GPU-less solutions, this powerful combination enables efficient on-device AI processing, expanding the possibilities for more edge intelligence applications. Internal tests have demonstrated the successful deployment of large-scale open-source AI models such as Qwen-1.8 B-Chat.

From business office to global travel these mobile broadband applied scenarios, Fibocom’s cost-effective 5G AI Mobile Hotspot solution—with optional Wi-Fi 7 support—paves the way for a new era of AI-enhanced mobile broadband. Welcome to visit Fibocom’s booth #K0727a at COMPUTEX 2025 to explore firsthand how its AI-powered connectivity solutions are unlocking the intelligent future of diversified industries.

China’s Aphranel MagiCCrystal CaHA Filler Debuts Globally, Ushering in a New Era of Regenerative Aesthetic Medicine

By
Advertorial Desk
-

SHANGHAI, May 21, 2025 /PRNewswire/ — On May 8, 2025, Shanghai Moyom Biotechnology Co., Ltd. unveiled its breakthrough regenerative aesthetic innovation, Aphranel MagiCCrystal CaHA Filler, during an international product debut at The Grand Halls in Shanghai, a historic building on the Bund. 

 

Presented under the theme “APHRANEL: Code Breaker, World Maker,“ the event welcomed senior policy makers, including Wu Changfei and Li Wei, as well as Ren Dawei, Deputy Director of the Shanghai Center for Biomedicine Development, who delivered the opening remarks. The scientific program featured keynote lectures from internationally recognized experts in plastic and aesthetic surgery—Prof. Qi Zuoliang, Prof. Cui Haiyan, Prof. Luo Shengkang, Prof. Chen Guangyu, Prof. Li Ya, and Dr. Stefan Lipp from Germany. The launch drew participation from physicians, key opinion leaders, and medical aesthetics associations, underscoring China’s growing role in the development of next-generation regenerative materials for aesthetic applications. 

China’s First Class III CaHA Filler Gains Global Regulatory Clearance

Aphranel MagiCCrystal CaHA Filler is the first injectable calcium hydroxylapatite (CaHA) microsphere-based dermal filler developed in China to receive NMPA Class III medical device certification. The formulation is engineered using proprietary manufacturing processes that allow precise modulation of particle size, porosity, and degradation rates. The filler’s ACD-MT™ “raspberry-like” through-hole microsphere morphology and PCD-ETT™ physically crosslinked gel matrix contribute to its favorable safety profile, structural integrity, and tissue integration—features that align with global standards in regenerative injectables.

The product has obtained EU Medical Device certification, MDSAP compliance, and regulatory clearance from Mexico’s COFEPRIS, enabling simultaneous market access across Asia, Europe, and Latin America. These designations mark a significant regulatory and scientific milestone for China-origin biomaterials in the global aesthetic sector.

World’s Top Plastic Surgeons Endorse Groundbreaking Chinese Formula

Lin Guangming, Chairman of Moyom Biotechnology, highlighted the company’s decade-long R&D journey during the product launch, emphasizing its commitment to “restoring the medical essence of aesthetic treatments”. This scientific rigor has enabled China’s transition from industry follower to global innovator, with Aphranel now delivering a precision-engineered “Chinese Solution” for controlled degradation and targeted anti-aging. 

The ceremonial highlight featured a butterfly release ceremony symbolizing the product’s transformation-driven therapeutic value. Moyom also announced 68 newly established clinical collaborations with global medical aesthetics centers, forming the basis for long-term multicenter studies and physician education initiatives. 

A clinical and scientific roundtable moderated by Moly.Nice founder Xiaodong brought together leading researchers and practicing clinicians to assess Aphranel’s bioengineering underpinnings. The expert panel validated the product’s therapeutic concept and endorsed its potential as a future standard in precision-based aesthetic medicine. Emphasis was placed on the brand’s “butterfly transformation” approach, with discussion centered on its relevance to longevity, safety, and patient-specific treatment outcomes. 

The launch concluded with a gala dinner co-presented by Shanghai Theatre Academy, featuring a groundbreaking fusion of jazz, classical, ballet and opera. The performance was designed to echo the product’s brand narrative of renewal and aesthetic harmony, presenting an East-West artistic dialogue that resonated with the event’s global audience.

https://youtu.be/OeW6k6jSrV4

China Sets New Global Benchmark in Anti-Aging Treatments
“Aphranel demonstrates how ‘Created in China‘ can achieve global excellence through medical innovation,” said Chairman Lin. “The innovation establishes new benchmarks for aesthetic safety and natural results worldwide.”

About Shanghai Moyom Biotechnology
Shanghai Moyom Biotechnology is a national high-tech enterprise and leading developer of premium medical aesthetic solutions. Specializing in nano-medical biomaterials and Class III absorbable implants, the company drives innovation across R&D, manufacturing, and clinical applications. 

SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine

By
Advertorial Desk
-
  • No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of PCV13 to Russia
  • Company plans to export PCV13 vaccine components
  • “We aim for the global PCV market with our 21-valent and next-generation pneumococcal vaccines currently under development.”

SEONGNAM, South Korea, May 21, 2025 /PRNewswire/ — SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it the Supreme Court of Korea has ruled in its favor in a patent infringement lawsuit filed by large global pharmaceutical giant Pfizer over its 13-valent pneumococcal conjugate vaccine (PCV13).

SK bioscience L HOUSE manufacturing plant
SK bioscience L HOUSE manufacturing plant

In 2020, Pfizer claimed that SK bioscience’s export of PCV13 individual conjugate bulk substances and research-use finished products to Russia infringed on the composition patent of its vaccine, Prevnar 13.

However, the Supreme Court ruled that the individual conjugates comprising PCV13 do not fall within the scope of Pfizer’s patent claims, thereby upholding the lower court’s ruling in favor of SK bioscience. The Court also confirmed that the production and supply of PCV13 finished products for research purposes did not constitute patent infringement.

SK bioscience successfully developed Korea’s first 13-valent pneumococcal conjugate vaccine, SKYPneumo, in 2016. However, due to the ongoing patent dispute with Pfizer, the company has been prohibited from manufacturing and selling the vaccine in Korea until 2027, when the related patents set to expire.

Following the ruling, SK bioscience now plans to initiate new business in pneumococcal conjugate vaccines by exporting individual components of PCV13 to countries with high vaccine demand, such as those in Southeast Asia and Latin America. Technology transfers through local partnerships are also being pursued in parallel.

Looking ahead, SK bioscience aims to expand its presence in the global pneumococcal vaccine market. From 2027, the company will be able to manufacture and sell SKYPneumo domestically. In addition, the company is developing a 21-valent pneumococcal conjugate vaccine with global pharmaceutical company Sanofi, which entered Phase 3 global clinical in late 2024. Simultaneously, the two companies are also working on a next-generation pneumococcal vaccine that is expected to offer broader protection than current options.

The global pneumococcal vaccine market continues to grow. According to Global Market Insights, the market is projected to grow at a compound annual rate of approximately 5.6% to reach USD 15.1 billion (approximately KRW 21.55 trillion) by 2034. This growth is driven by expanded vaccination programs and support from governments and international organizations like WHO and Gavi. SK bioscience’s strong track record in public vaccine supply and cooperation with global health organizations positions it well for future expansion.

Jaeyong Ahn, CEO of SK bioscience, said, “This latest court decision is meaningful in that it ensures a competitively developed vaccine in Korea does not go to waste but instead finds new opportunity. We will leverage this momentum to improve access to premium vaccines, contribute to a stable global vaccine supply, and achieve sustainable growth.”

Meanwhile, SK bioscience recently secured a definitive legal victory in a patent invalidation suit against Moderna, successfully challenging the biotech giant’s Korean patent related to messenger RNA (mRNA) vaccine technology. The contested patent covers ‘modified nucleosides, nucleotides, and nucleic acids and their uses.’ This case, which invalidated the only registered mRNA manufacturing patent in Korea, regarded as a major step in reducing patent-related risks and removing barriers to innovation for domestic companies engaged in mRNA research and development.

About SK bioscience

SK bioscience is an innovative vaccine and biotech company, committed to vaccine development and manufacturing to enable more equitable access to vaccines around the world. Leveraging strengths on cutting-edge technologies, SK bioscience has been dedicated to promoting human health from prevention to cure across the globe. With the cooperation of domestic and international governments, regulatory agencies, healthcare providers, doctors, and medical experts, all of the SK colleagues are passionately committed to providing high-quality vaccines to those who need them and better public healthcare solutions.

– SK bioscience Website

– SK bioscience Linkedin

Contact

SK bioscience Communications Team

Changhyun Jin (jin99@sk.com)

Jeannie S. Pak (j.pak@sk.com)

 

MAXSUN Unveils Intel Arc Pro B60 Dual 48G Turbo at COMPUTEX 2025

By
Advertorial Desk
-

TAIPEI, May 21, 2025 /PRNewswire/ — MAXSUN is showcasing its latest breakthrough product at COMPUTEX 2025, the MAXSUN Intel Arc Pro B60 Dual 48G Turbo graphics card. Featuring dual-GPU architecture, 48GB of GDDR6 memory, and dual hardware media engines, this powerhouse is engineered for the most demanding AI inference and video processing workloads. The card delivers exceptional performance, offering high-speed data processing, accelerated AI capabilities, and efficient video encoding/decoding. It is a game-changer for professionals requiring cutting-edge hardware for intensive tasks.

MAXSUN at COMPUTEX2025
MAXSUN at COMPUTEX2025

With this launch, we’re further reinforcing our commitment to delivering high-value AI and workstation hardware—offering developers, AI enthusiasts, and enterprise users a new high-efficiency, cost-effective computing solution purpose-built for the AI era.

MAXSUN Intel Arc B580 and B60 Series Graphics Cards

In addition to the MAXSUN Intel Arc Pro B60 Dual 48G Turbo, MAXSUN is displaying the Intel Arc B580 series graphics cards. These cards offer high-frequency output and advanced cooling solutions, making them ideal for both gaming and professional applications. They are designed to provide stable, powerful performance under heavy workloads.

High-Performance Motherboards: MS-iCraft Z890 Series

MAXSUN is also presenting its MS-iCraft Z890 series motherboards, including the Z890 Vertex and Z890 Pacific. These high-performance boards are designed for gaming and demanding builds, offering robust stability and support for the latest components. The MAXSUN iCraft B860m Cross Pro motherboard, with its anime styl design and solid performance, is also receiving attention from attendees.

Workstation Solutions: MS-WorkStation W790 and MS-Q670M vPro

For professional applications, MAXSUN is showcasing the MS-WorkStation W790 112L motherboard. Designed for high-performance workstations, it’s ideal for tasks such as video editing, 3D rendering, and scientific computing. Additionally, the MS-Q670M vPro motherboard is tailored for enterprise environments, offering reliability and security for business use.

Specialty Gaming Products: MS-Terminator B850M PRO WIFI

The MS-Terminator B850M PRO WIFI motherboard stands out with its battle armor-inspired design. The full metal armor enhances cooling performance, making it ideal for gamers who need both style and durability in their builds.

Visit MAXSUN at COMPUTEX 2025
MAXSUN’s products will be showcased at COMPUTEX 2025, May 20–23, 2025 in Hall 1, 4th Floor, Booth L1118. Visitors will have the chance to experience hands-on demos and learn more about MAXSUN’s cutting-edge products.

Contact:
Marketing@maxsun.com

Photo – https://laotiantimes.com/wp-content/uploads/2025/05/maxsun_computex2025-1.jpg

 

Ping An’s EagleX Risk Mitigation Platform Provides Early Warning of Beijing Hailstorm, Company Streamlines Claims Settlement

By
Advertorial Desk
-
  • On May 13, a severe hailstorm struck multiple areas in Beijing, causing significant property damage
  • Ping An’s AI-powered risk mitigation platform, EagleX issued an alert to customers two hours in advance, helping to minimize losses

HONG KONG and SHANGHAI, May 21, 2025 /PRNewswire/ — On May 13, Beijing was hit by a severe storm in multiple areas, with reports of hailstones exceeding 3 cm in diameter. Ping An P&C, a subsidiary of Ping An Insurance (Group) Company of China, Ltd. (“Ping An”, the “Company” or the “Group”, HKEX: 2318; SSE: 601318) launched its major emergency response plan, coordinating resources across risk control, claims, and product departments. The Company mobilized over 2,000 personnel from 38 branch offices for remote support and swiftly dispatched 43 claims experts from Hebei, Shandong, Henan, Liaoning, and other provinces to Beijing for disaster relief.

As of 9 a.m. on May 19, Ping An P&C received 31,000 claims reports, settled 10,400 cases, and paid out RMB62.15 million in compensation.

EagleX issued alerts two hours before the storm

Ping An P&C’s proprietary risk mitigation platform, EagleX, played a critical role. The system detected risks two hours before the hailstorm arrived and sent warnings, disaster prevention guides, and safety tips to 3.17 million individual customers and over 20,000 corporate clients via apps such as Ping An Auto Owner. The alerts helped some customers move their vehicles and secure their properties in time, effectively reducing potential losses.

EagleX is an AI-powered risk mitigation service platform developed by Ping An P&C to address climate-related disasters. It integrates cutting-edge technologies such as big data, satellite remote sensing, and machine learning to monitor, assess, and provide early alerts for nine types of natural disasters. It also displays natural disaster risk maps. The system has been widely applied across various insurance products, including agricultural insurance, property insurance, and auto insurance.

Claims settlement streamlined to respond quickly to customers’ needs

Faced with numerous customer claims after the hailstorm, Ping An P&C ensured that reporting channels remained open around the clock, with over 90% of affected customers receiving callbacks on the same day. The Company collaborated with rescue teams and repair shops to prioritize services for damaged vehicles, offering towing, emergency repairs, and direct supply of auto parts, while committing to “1-hour rescue response and 48-hour repair completion”.

In the claims process, Ping An P&C introduced “streamlined claims settlement”, which waives proof of accident or weather event. No on-site inspection is necessary, and rescue services are offered for free. For cases involving damages of less than RMB10,000, photo or video evidence is sufficient for claims settlement. In cases of hail damage, the Company is offering specialized services such as instant on-site glass replacement and “traceless repairs” for minor auto damage. Additionally, customers who have made no claims in the past three years can receive direct approval for expenses under RMB2,000.

Ping An P&C will continue to advance claims processing in an orderly manner and, leverage EagleX to further enhance pre-disaster alerts, emergency responses during disasters, and post-disaster claims settlements. The Company aims to help customers reduce losses, enhance risk management capabilities, and safeguard the property of businesses and individuals.

About Ping An Group
 Ping An Insurance (Group) Company of China, Ltd. (HKEx:2318 / 82318; SSE:601318) is one of the largest financial services companies in the world. It strives to become a world-leading provider of integrated finance, health and senior care services. Under the technology-driven “integrated finance + health and senior care” strategy, the Group provides professional “financial advisory, family doctor, and senior care concierge” services to its nearly 240 million retail customers. Ping An advances intelligent digital transformation and employs technologies to improve financial businesses’ quality and efficiency and enhance risk management. The Group is listed on the stock exchanges in Hong Kong and Shanghai. As of the end of December 2024, Ping An had more than RMB12 trillion in total assets. The Group ranked 29th in the Forbes Global 2000 list in 2024 and 53rd in the Fortune Global 500 list in 2024. 

For more information, please visit www.group.pingan.com and follow us on LinkedIn – PING AN.

 

1...3,1023,1033,104...6,364Page 3,103 of 6,364